Regulatory sanctions for ethically relevant GCP violations
Related Experiment Video
Updated: Jan 22, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Rosemarie de la Cruz Bernabe1, Ghislaine J M W van Thiel2, Nancy S Breekveldt3
1Centre for Medical Ethics, Institute of Health and Society, University of Oslo, Oslo, Norway.
Abstract:
Although EU inspectors and clinical assessors are mandated to identify and act upon ethical issues, regulators lack guidance on how this can be done. Hence, we propose a four-step regulatory approach on ethically relevant GCP violation findings. The first step is identification of the ethical issue. Next is analysis [i.e., identifying the gravity (intensity or severity) and the magnitude (amount and duration) of the ethics violation as well as the responsible person(s) or entity or entities]. The third step is evaluation, (i.e., the process of deliberating to determine the significance of the ethics violation, with the intention of identifying the most reasonable sanction and/or corrective or reparative action). Last is decision-making or the process of choosing and implementing a regulatory course of action.
Related Concept Videos
Ethics in Research
Cis-regulatory Sequences
Ethics and Bioethics
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas II
Ethical Standards I
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

